Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Online peer education to encourage daily walking in adults with type 2 diabetes

Tests online peer education to help adults with type 2 diabetes walk more.

Plain-language title generated from the registry record
Registry title: HOPE Intervention for Fitness

Key facts

Where
Irvine, United StatesSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults in the US who say they have type II diabetes and use an app to count their steps. It tests a way to help people walk more.

Age
18 years or older
Sex
All sexes can join
Disease stage
Type II diabetes, as reported by the person themselves
Earlier treatment
People on insulin or an injectable weight loss drug cannot join.

Main reasons for not taking part

  • Taking insulin
  • Taking an injectable weight loss drug

Read by machine on 9 November 2026.

Where in United States

  • UC IrvineIrvine, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of California, Irvine
Trial code
NCT07114822
Record updated
26 August 2026
Original description
We will test the HOPE intervention on changing behavior of people to exercise more (take more steps each day).Read full original descriptionShow less

Harnessing Online Peer Education For Fitness in People With Type II Diabetes

We will test the HOPE intervention on changing behavior of people to exercise more (take more steps each day).

Inclusion: 18 years or older; Living in the US; Self-report diagnosis of type II diabetes; Has an app to track step count.

Exclusion: On insulin or an injectable weight loss drug.

ClinicalTrials.gov NCT07114822